Therefore, MMP inhibition by TCs might explain the beneficial role of such agents in controlling COVID-19–induced ARDS as evident by the reduction of IL-6 serum levels (McGonagle et al., 2020). Here, IL6 is linked to acute respiratory distress syndrome.